In 2017,company has been dramatically growing with important progresses in all businesses. Looking forward to the future, the company intends to reinforce its position as a leading biopharmaceutical company in China by leveraging its integrated R&D, commercial and manufacturing platforms.

Cover the whole process of drug development, ranging from basic research, pre-clinical research, clinical trial to new drug registration and marketing.

we have a wealth of product series under study, with nearly 30 kinds of listed products and 25 kinds of alternative products.

Always focus on high-quality drugs to improve the quality of life of patients for the benefit of human health.